It is widely beliebed that China has not yet established uniform quality standards and inspection units for approval procedures and monitoring rules of clinical research and applications of stem cells. Administration officials at the China Food and Drug Administration, academia and industry become ready to enhance stem cell research and translation into hospitals.

China Bio Network, April 2, 2014